Memory CD8+ T cell responses to cancer
…, N Khatwani, TG Searles, MJ Turk, CV Angeles - Seminars in …, 2020 - Elsevier
Long-lived memory CD8 + T cells play important roles in tumor immunity. Studies over the
past two decades have identified four subsets of memory CD8 + T cells - central, effector, stem-…
past two decades have identified four subsets of memory CD8 + T cells - central, effector, stem-…
Resident memory T cells in the skin mediate durable immunity to melanoma
…, AK Molodtsov, JS Bowers, CV Angeles… - Science …, 2017 - science.org
Tissue-resident memory T (T RM ) cells have been widely characterized in infectious disease
settings; however, their role in mediating immunity to cancer remains unknown. We report …
settings; however, their role in mediating immunity to cancer remains unknown. We report …
Resident and circulating memory T cells persist for years in melanoma patients with durable responses to immunotherapy
While T-cell responses to cancer immunotherapy have been avidly studied, long-lived
memory has been poorly characterized. In a cohort of metastatic melanoma survivors with …
memory has been poorly characterized. In a cohort of metastatic melanoma survivors with …
[PDF][PDF] Resident memory CD8+ T cells in regional lymph nodes mediate immunity to metastatic melanoma
…, SL Wong, JD Phillips, K Shirai, CV Angeles… - Immunity, 2021 - cell.com
The nature of the anti-tumor immune response changes as primary tumors progress and
metastasize. We investigated the role of resident memory (Trm) and circulating memory (Tcirm) …
metastasize. We investigated the role of resident memory (Trm) and circulating memory (Tcirm) …
WNT signaling in the tumor microenvironment promotes immunosuppression in murine pancreatic cancer
…, X He, ES Carpenter, CV Angeles… - Journal of Experimental …, 2022 - rupress.org
Pancreatic ductal adenocarcinoma (PDA) is associated with activation of WNT signaling.
Whether this signaling pathway regulates the tumor microenvironment has remained …
Whether this signaling pathway regulates the tumor microenvironment has remained …
Frequent alterations and epigenetic silencing of differentiation pathway genes in structurally rearranged liposarcomas
BS Taylor, PL DeCarolis, CV Angeles, F Brenet… - Cancer discovery, 2011 - AACR
We explored diverse alterations contributing to liposarcomagenesis by sequencing the
genome, exome, transcriptome, and cytosine methylome of a primary and recurrent …
genome, exome, transcriptome, and cytosine methylome of a primary and recurrent …
Immunotherapy for Merkel cell carcinoma
CV Angeles, MS Sabel - Journal of Surgical Oncology, 2021 - Wiley Online Library
Merkel cell carcinoma (MCC) is an aggressive form of skin cancer which, while chemosensitive,
has high rates of relapse and chemoresistance, limiting the impact of chemotherapy. An …
has high rates of relapse and chemoresistance, limiting the impact of chemotherapy. An …
Myeloid cells that impair immunotherapy are restored in melanomas with acquired resistance to BRAF inhibitors
…, BT Malik, TA Wood, A Boni, A Molodtsov, CV Angeles… - Cancer research, 2017 - AACR
Acquired resistance to BRAF V600E inhibitors (BRAFi) in melanoma remains a common
clinical obstacle, as is the case for any targeted drug therapy that can be developed given the …
clinical obstacle, as is the case for any targeted drug therapy that can be developed given the …
Expression profiling of liposarcoma yields a multigene predictor of patient outcome and identifies genes that contribute to liposarcomagenesis
Liposarcomas are the most common type of soft tissue sarcoma but their genetics are poorly
defined. To identify genes that contribute to liposarcomagenesis and serve as prognostic …
defined. To identify genes that contribute to liposarcomagenesis and serve as prognostic …
VISTA expression on tumor-infiltrating inflammatory cells in primary cutaneous melanoma correlates with poor disease-specific survival
…, JL Fisher, C Cheng, RJ Noelle, CV Angeles… - Cancer Immunology …, 2018 - Springer
Adaptive immune responses contribute to the pathogenesis of melanoma by facilitating
immune evasion. V-domain Ig suppressor of T-cell activation (VISTA) is a potent negative …
immune evasion. V-domain Ig suppressor of T-cell activation (VISTA) is a potent negative …